GB201700502D0 - Treatment of tumours of the central nervous system - Google Patents

Treatment of tumours of the central nervous system

Info

Publication number
GB201700502D0
GB201700502D0 GBGB1700502.6A GB201700502A GB201700502D0 GB 201700502 D0 GB201700502 D0 GB 201700502D0 GB 201700502 A GB201700502 A GB 201700502A GB 201700502 D0 GB201700502 D0 GB 201700502D0
Authority
GB
United Kingdom
Prior art keywords
tumours
treatment
nervous system
central nervous
central
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1700502.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BenevolentAI Bio Ltd
Original Assignee
BenevolentAI Bio Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BenevolentAI Bio Ltd filed Critical BenevolentAI Bio Ltd
Priority to GBGB1700502.6A priority Critical patent/GB201700502D0/en
Publication of GB201700502D0 publication Critical patent/GB201700502D0/en
Ceased legal-status Critical Current

Links

GBGB1700502.6A 2017-01-11 2017-01-11 Treatment of tumours of the central nervous system Ceased GB201700502D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB1700502.6A GB201700502D0 (en) 2017-01-11 2017-01-11 Treatment of tumours of the central nervous system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1700502.6A GB201700502D0 (en) 2017-01-11 2017-01-11 Treatment of tumours of the central nervous system

Publications (1)

Publication Number Publication Date
GB201700502D0 true GB201700502D0 (en) 2017-02-22

Family

ID=58463738

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1700502.6A Ceased GB201700502D0 (en) 2017-01-11 2017-01-11 Treatment of tumours of the central nervous system

Country Status (1)

Country Link
GB (1) GB201700502D0 (en)

Similar Documents

Publication Publication Date Title
IL289650A (en) Azolopyrimidine for the treatment of cancer-related disorders
IL271085A (en) Bacteria for the treatment of disorders
SI3600281T1 (en) Combination therapy for the treatment or prevention of tumours
ZA201905902B (en) 2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancer
HK1247129A1 (en) Combination therapy for the treatment of cancer
IL258471A (en) 11,13-modified saxitoxins for the treatment of pain
HK1251475A1 (en) Combination therapy for the treatment of cancer
IL267795A (en) Combination therapy for the treatment of cancer
IL259996A (en) Combinations for the treatment of cancer
IL266993A (en) Combination therapy for the treatment of cancer
ZA201901578B (en) Combinations including abx196 for the treatment of cancer
GB201607388D0 (en) Treatment of impulsivity-related disorders
GB201614415D0 (en) Enzymes for the treatment of human enterometabolic dysfunction
GB201520600D0 (en) Treatment of central nervous tumours
EP3603635A4 (en) Use of melatonin for the treatment of tumours
IL253642A0 (en) Combination therapy for the treatment of cancer
GB201700502D0 (en) Treatment of tumours of the central nervous system
GB201817903D0 (en) Anticancer treatment
GB201519841D0 (en) Treatment of central nervous tumours
PT3580211T (en) 2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancer
GB201518002D0 (en) Ketamine for the treatment of somatoform pain disorder
GB201602784D0 (en) New treatment of CFTR-related disorders
EP3116507A4 (en) Treatment of brain and central nervous system tumors
GB201413533D0 (en) Combination therapy for treating disorders of the vestibular system

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)